Investors Communication

-----------------------------

"This Presentation, except for the historical information, may contain statements, including the words or phrases such as 'expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should' and similar expressions or variations of these expressions or negatives of these terms indicating future performance or results, financial or otherwise of Tata Chemicals Limited, its direct and indirect subsidiaries and its associates. Actual results might differ substantially or materially from those expressed or implied. Important factors that could make a difference to the Company's operations include, among others, economic conditions affecting demand / supply, price conditions in the domestic and overseas markets in which the Company operates, changes in Government policies and regulations, tax laws, and other statutes and incidental factors. You are urged to view all statements contained herein with caution. Tata Chemicals Limited does not undertake any obligation to update or revise forward look statements, whether as a result of new information, future events or otherwise"

2

3

Q4 FY23

12M FY23

₹ 4,407 Cr (CY) vs ₹ 3,481 Cr (PY)

₹ 16,789 Cr (CY) vs ₹ 12,622 Cr (PY)

₹ 965 Cr (CY) vs. ₹ 657 Cr (PY)

₹ 3,822 Cr (CY) vs. ₹ 2,305 Cr (PY)

₹ 686 Cr (CY) vs ₹ 513 Cr (PY)

₹ 2,740 Cr (CY) vs ₹ 1,667 Cr (PY)

₹ 694 Cr (CY) vs ₹ 470 Cr (PY) ₹ 2,452 Cr (CY) vs ₹ 1,400 Cr (PY)

Gross Debt

₹ 7,024 Cr

728

₹ 6,296 Cr

(Mar 22)

(Mar 23)

Net Debt

₹ 4,232 Cr

334

₹ 3,898 Cr

(Mar 22)

(Mar 23)

  • Higher revenue on account of better realizations and stable demand
  • EBITDA growth driven by higher realizations in all geographies
  • Proposed Dividend of ₹ Rs. 17.5 per share (subject to approval of shareholders at AGM)
  • Gross debt lower due to prepayment of debt US$ 155 Mn in overseas units during the year (Rs 1,247 Cr)
    • Gross debt down from US $ 930 Mn to US $ 770 Mn
    • Gross and Net debt include a forex revaluation impact of Rs 458 Cr

4

Revenue

4,148 4,407

3,481

Q4 Mar 22 Q3 Dec 22 Q4 Mar 23

Revenue up by ₹ 926 Crore (↑27%)

Consolidated | ₹ Crore

EBITDA

Profit Before Tax

922

965

657

513

534

686

Q4 Mar 22 Q3 Dec 22

Q4 Mar 23

Q4 Mar 22

Q3 Dec

22 Q4 Mar 23

EBITDA up by ₹ 308 Crore (↑47%)

PBT up by ₹ 173 Crore (↑34%)

Profit After Tax

694

470 432

Q4 Mar 22 Q3 Dec 22 Q4 Mar 23

PAT up by ₹ 224 Crore (↑48%)

Standalone | ₹ Crore

Revenue

EBITDA

Profit Before Tax

Profit After Tax

1,218

1,302

1,115

316

269

276

284

244

249

259

190

213

Q4 Mar 22 Q3 Dec 22 Q4 Mar 23

Q4 Mar 22 Q3 Dec 22 Q4 Mar 23

Q4 Mar 22 Q3 Dec 22

Q4 Mar 23

Q4 Mar 22 Q3 Dec 22 Q4 Mar 23

Revenue up by ₹ 187 Crore (↑17%)

EBITDA down by ₹17 Crore (↓ 6%)

PBT down by ₹ 67 Crore (↓21%)

PAT down by ₹ 56 Crore (↓21%)*

Note: Change is vs PY quarter

*Q4FY22 profit was higher due to tax refund of ~Rs. 60 cr.

PBT & PAT includes continuing operations, after share in JV & associates & before Non-Controlling Interest

5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Tata Chemicals Limited published this content on 03 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 May 2023 11:45:16 UTC.